This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Cramer's 'Mad Money' Recap: Next Week's Game Plan

Thanks to some smart acquisitions, Boston Scientific is poised to debut everything from new asthma treatments to better implantable defibrillators, most of which won't move the needle until 2014, said Cramer, but that means the time to get into the stock is today. The company is also being helped by growth overseas, which has helped not only stabilize sales, but prompted management to declare that a small increase in revenue is possible in the second half of 2013.

Boston Scientific trades at just 12.5 times earnings, said Cramer, but with growth returning the stock could fetch a multiple to match that of its peers, which would value the stock a full 26% higher than it trades today. Shares have already had a big rally, Cramer admitted, but there's still definitely room to run.

Hidden Potential

Sometimes the sum of the parts are worth more than the whole, Cramer reminded viewers as he highlighted yet another company with hidden potential to bring out value, if only its management realized that breaking up would be the best thing for shareholders.

Cramer said that Baxter International (BAX) could follow in the footsteps of Abbott Laboratoriess (ABT), which spun off its AbbVie (ABBV) division to huge gains.

Cramer explained that while Baxter is only up 9% so far this year, the company could do so much better if only it split its pharma business, which makes vaccines and other bioscience products, from its medical device business. He said combined as a single company, Baxter gets lost in the shuffle. But as two separate companies, analysts and investors would not only take notice, but also be able to assign full value to its parts.

Cramer reminded viewers that since its split, Abbott Labs is up 12%, while AbbVie is up 33%. Johnson & Johnson (JNJ) has rallied 42% over the past 12 months on the mere speculation that the company might split itself into four units.

So what's Baxter really worth? Cramer valued the pharma business at $56 a share and the company's medical devices at another $31 a share, giving the company a total value of $87.50 a share, or 19.5% higher than it trades today.

Lightning Round

In the Lightning Round, Cramer was bullish on Ubiquiti Networks (UBNT), Cornerstone OnDemand (CSOD) and Heckmann (HEK).

Cramer was bearish on Potash (POT).

Mad Tweets

In the "Mad Tweets" segment, Cramer responded to questions sent via Twitter to @JimCramer.

He said Radian Group (RDN) remains very undervalued.

Cramer told another tweeter that investors should always reinvest their dividends. Always.

No Huddle Offense

In his "No Huddle Offense" segment, Cramer opined on the horrendous IPO of Facebook (FB), a stock he owns for his charitable trust, Action Alerts PLUS . The first anniversary of that IPO is Saturday.

Cramer likened the Facebook IPO to a man-made forest fire, saying the IPO was a sad event for all those involved and especially those who love the markets as much as he does.

He said the combination of a greedy company, lopsided market information and an untrustworthy system led to institutional and inside investors cashing out just as millions of individual investors were buying in.

Since its IPO, Facebook has been able to re-engineer its mobile strategy, but it has never been able to regain the trust of Wall Street, said Cramer. He said Action Alerts PLUS owns the stock as a long-term speculation and has yet to be rewarded. Meanwhile, Cramer said he can't blame any investor for still not trusting the company.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had a position in FB, JNJ and TJX.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for TheStreet.com, Inc., and CNBC, and a director and co-founder of TheStreet.com. All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of TheStreet.com or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither TheStreet.com, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or TheStreet.com is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, TheStreet.com or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor TheStreet.com, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on TheStreet.com. The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in TheStreet.com, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.

2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs